Completed PHASE4 INTERVENTIONAL 4-arm NCT05488925

Comparison of Preoperative Analgesics on the Efficacy of Inferior Alveolar Nerve Block.

Comparison of Preoperative Analgesics on the Efficacy of Inferior Alveolar Nerve Block on Patients With Symptomatic Irreversible Pulpitis: a Double Blinded, Randomized Controlled Trial.

Sponsor: Farjad Zafar

Conditions Symptomatic Irreversible Pulpitis

Interventions Diclofenac Sodium Piroxicam Tramadol Vitamin E

Updated 3 times since 2022 Last updated: Aug 3, 2022 Started: Jun 21, 2021 Primary completion: Feb 18, 2022 Completion: Feb 18, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05488925, this PHASE4 trial focuses on Symptomatic Irreversible Pulpitis and remains completed. Sponsored by Farjad Zafar, it has been updated 3 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Sep 2022 — Jul 2024 [monthly]

Completed PHASE4

First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Farjad Zafar

Data source: Baqai Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan